- Home
- PRQR vs LFCR Comparison
PRQR vs LFCR Comparison
Compare PRQR & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | LFCR |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.5M | 143.9M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PRQR | LFCR |
|---|---|---|
| Price | $1.51 | $5.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $6.80 | $5.50 |
| AVG Volume (30 Days) | ★ 774.0K | 357.7K |
| Earning Date | 05-07-2026 | 08-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.92 | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.33 | $3.63 |
| 52 Week High | $3.10 | $8.98 |
Technical Indicators
Market Signals| Indicator | PRQR | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 51.35 |
| Support Level | $1.34 | $3.63 |
| Resistance Level | $1.58 | $8.60 |
| Average True Range (ATR) | 0.16 | 0.32 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 0.71 | 68.79 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.